Jocelyne Papacharalambous, M.D., MPH

Executive Medical Director, Medical Development

Jocelyne joined AnaptysBio in November of 2022 in the role of Executive Medical Director, on the Medical Development team. Jocelyne has extensive corporate and consulting expertise with such companies as Pfizer, Takeda, and Bristol Meyers Squibb in various role within R&D which includes Medical Monitoring, Clinician Physician, and clinical lead. Her experience extends into patient care in dermatology, oncology, cardiovascular and neuroscience, and most recently, NASH Cirrhosis. Her passion includes her desire to provide clinical/scientific knowledge while developing, executing, and communicating global scientific/medical evidence plans for various indications while supporting cross-functional teams. Jocelyne has developed successful criteria for Phases I, II, and III studies for candidate studies. Her educational background includes an MPH, Maternal and Child Health from George Washington University, and an M.D. from George Washington University, and an M.D. from St. Matthew’s University, UK.